Lv11
10 积分 2024-05-14 加入
Mining and influencing factors analysis of sacituzumab govitecan adverse drug event based on FAERS database
2小时前
待确认
Review of the mechanism of action of coal tar in psoriasis
4个月前
已完结
Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data
4个月前
已完结
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo
6个月前
已完结
Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System
6个月前
已完结
皖公网安备34019202002308
